Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
285
datasets available to search
ShareScore release 0.9.0
Dataset results
285 results for “regorafenib”
Neoadjuvant Regorafenib in Combination with Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer
ClinicalTrials.gov study NCT04503694. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7
ClinicalTrials.gov study NCT04777851. IPD Sharing: Not stated. Countries: 13. Publications: 0.
Study to Determine the Efficacy of Regorafenib in Metastatic Colorectal Cancer Patients and to Discover Biomarkers
ClinicalTrials.gov study NCT01949194. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety Study of Regorafenib With PF-03446962 to Treat Colorectal Cancer
ClinicalTrials.gov study NCT02116894. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cadonilimab Plus Regorafenib and Gem-Cis Chemotherapy in Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT05820906. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer
ClinicalTrials.gov study NCT07040228. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase II Study of Regorafenib as Maintenance Therapy
ClinicalTrials.gov study NCT03793361. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of Regorafenib and Toripalimab Combined With RFA in Patients With CRCLM
ClinicalTrials.gov study NCT05485909. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib and PD-1 Antibody in Combination With Radiotherapy for pMMR/MSS Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT04030260. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of CS1001 in Combination With Regorafenib in Patients With Advanced or Refractory Solid Tumors
ClinicalTrials.gov study NCT04200404. IPD Sharing: Not stated. Countries: 1. Publications: 0.
STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer
ClinicalTrials.gov study NCT07213570. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination of LTC004 and Regorafenib to Treat Patients With Advanced/Metastatic CRC
ClinicalTrials.gov study NCT06322563. IPD Sharing: NO. Countries: 1. Publications: 0.
An Observational Study to Learn More About the Long-Term Responses to Treatment With Regorafenib in Patients With Metastatic Colorectal Cancer in the United States
ClinicalTrials.gov study NCT06029010. IPD Sharing: NO. Countries: 1. Publications: 0.
RE-SEARCH Study: A Study to Learn How and in Which Amount Regorafenib is Given in Usual Practice to Patients in Spain: a Study Looking Back at Cases That Have Already Happened When the Study Begins.
ClinicalTrials.gov study NCT04920422. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of Neomycin on the Pharmacokinetics of Regorafenib
ClinicalTrials.gov study NCT02001909. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT05328908. IPD Sharing: Not stated. Countries: 22. Publications: 0.
Regorafenib in Reducing Recurrence in Patients With Non-metastatic Rectal Cancer Who Have Completed Curative-Intent Treatment
ClinicalTrials.gov study NCT02287727. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas
ClinicalTrials.gov study NCT04055220. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)
ClinicalTrials.gov study NCT04170556. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard Treatment
ClinicalTrials.gov study NCT06772233. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.